(Q42660244)

English

Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects

scientific article published on July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Ying-Jun Cao

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Patrick F Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Mary Beth Wire

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Yu Lou

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Charles T Lancaster

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Roger C Causon

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

George E Bigelow

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Elizabeth Martinez

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Edward J Fuchs

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Christine Radebaugh

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sarah McCabe

11

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Craig W Hendrix

12

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

0 references

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

863-874

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Stereoselective pharmacokinetics of methadone in chronic pain patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Enantiomeric metabolic interactions and stereoselective human methadone metabolism

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Weak Binding of VX-478 to Human Plasma Proteins and Implications for Anti-Human Immunodeficiency Virus Therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Decreased methadone effect after ritonavir initiation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug users

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Effects of buprenorphine and methadone in methadone-maintained subjects.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.7.863

21 January 2018

Identifiers

10.1592/PHCO.28.7.863

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42660244&oldid=2144128957"